NGM BIOPHARMACEUTICALS INCNGM BIOPHARMACEUTICALS INCNGM BIOPHARMACEUTICALS INC

NGM BIOPHARMACEUTICALS INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪118.27 M‬EUR
−1.57EUR
‪−128.99 M‬EUR
‪4.00 M‬EUR
‪67.27 M‬
Beta (1Y)
0.59

About NGM BIOPHARMACEUTICALS INC

CEO
David J. Woodhouse
Website
Headquarters
South San Francisco
Employees (FY)
138
Founded
2007
NGM Biopharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel biologic drug candidates. Its programs include NGM707 and pembrolizumab for treating metastatic solid tumors, Aldafermin for primary sclerosing cholangitis, and NGM120 for hyperemesis gravidarum. The company was founded by Jin Long Chen on December 20, 2007 and is headquartered in South San Francisco, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0IK is 1.44 EUR — it has decreased by 0.69% in the past 24 hours. Watch NGM BIOPHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange NGM BIOPHARMACEUTICALS INC stocks are traded under the ticker 0IK.
0IK reached its all-time high on Mar 18, 2021 with the price of 26.40 EUR, and its all-time low was 0.55 EUR and was reached on Nov 21, 2023. View more price dynamics on 0IK chart.
See other stocks reaching their highest and lowest prices.
0IK stock is 0.69% volatile and has beta coefficient of 0.59. Track NGM BIOPHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is NGM BIOPHARMACEUTICALS INC there?
Today NGM BIOPHARMACEUTICALS INC has the market capitalization of ‪118.36 M‬, it has decreased by 0.82% over the last week.
Yes, you can track NGM BIOPHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
NGM BIOPHARMACEUTICALS INC is going to release the next earnings report on May 21, 2024. Keep track of upcoming events with our Earnings Calendar.
0IK earnings for the last quarter are −0.30 EUR per share, whereas the estimation was −0.36 EUR resulting in a 16.09% surprise. The estimated earnings for the next quarter are −0.34 EUR per share. See more details about NGM BIOPHARMACEUTICALS INC earnings.
NGM BIOPHARMACEUTICALS INC revenue for the last quarter amounts to ‪149.49 K‬ EUR despite the estimated figure of ‪505.74 K‬ EUR. In the next quarter revenue is expected to reach ‪161.82 K‬ EUR.
0IK net income for the last quarter is ‪−25.07 M‬ EUR, while the quarter before that showed ‪−27.24 M‬ EUR of net income which accounts for 7.97% change. Track more NGM BIOPHARMACEUTICALS INC financial stats to get the full picture.
No, 0IK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 21, 2024, the company has 138.00 employees. See our rating of the largest employees — is NGM BIOPHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NGM BIOPHARMACEUTICALS INC EBITDA is ‪−129.82 M‬ EUR, and current EBITDA margin is ‪−3.27 K‬%. See more stats in NGM BIOPHARMACEUTICALS INC financial statements.
Like other stocks, 0IK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NGM BIOPHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NGM BIOPHARMACEUTICALS INC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NGM BIOPHARMACEUTICALS INC stock shows the sell signal. See more of NGM BIOPHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.